BERKELEY, CA (UroToday.com) - Urothelial carcinoma of the bladder (UCB) is one of the most prevalent types of cancer with high recurrence rates in the non-muscle invasive (NMIBC) type.
To validate vascular endothelial growth factor receptor-1 (VEGFR1) single nucleotide polymorphism (SNP) rs9582036 as a potential predictive biomarker in metastatic clear-cell renal cell carcinoma (m-ccRCC) patients treated with sunitinib.
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
